Considerations for adding pneumonia and influenza vaccines to public health programmes

被引：3

作者：

Miller, MA ^{[1
]}

机构：

[1] WHO, Childrens Vaccine Intiat, CH-1211 Geneva 27, Switzerland

来源：

关键词：

D O I：

10.1016/S0264-410X(99)00115-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：S95 / S98

页数：4

共 31 条

[1] A FRAMEWORK FOR THE EVALUATION OF VACCINES FOR USE IN THE EXPANDED PROGRAM ON IMMUNIZATION
AYLWARD, B
KANE, M
BATSON, A
SCOTT, RM
[J]. VACCINE, 1994, 12 (13) : 1155 - 1159
[2] Win-win interactions between the public and private sectors
Batson, A
[J]. NATURE MEDICINE, 1998, 4 (05) : 487 - 491
[3] PNEUMOCOCCAL VACCINE EFFICACY IN SELECTED POPULATIONS IN THE UNITED-STATES
BOLAN, G
BROOME, CV
FACKLAM, RR
PLIKAYTIS, BD
FRASER, DW
SCHLECH, WF
[J]. ANNALS OF INTERNAL MEDICINE, 1986, 104 (01) : 1 - 6
[4] Cost-effectiveness of the influenza vaccine in a healthy, working-age population
Campbell, DS
Rumley, MH
[J]. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1997, 39 (05) : 408 - 414
[5] *CDCP, 1995, MMWR-MORBID MORTAL W, V44, P506
[6] Elo O, 1979, Dev Biol Stand, V43, P419
[7] Influenza vaccination in 22 developed countries: an update to 1995
Fedson, DS
Hirota, Y
Shin, HK
Cambillard, PE
Kiely, J
Ambrosch, F
Hannoun, C
Leese, J
Sprenger, MJW
Hampson, AW
BroJorgensen, K
Ahlbom, AM
Nokleby, H
Valle, M
Olafsson, O
Salmeron, F
Cloetta, J
deAndrade, HR
Snacken, R
Donatelli, I
Jennings, LC
Strikas, RA
[J]. VACCINE, 1997, 15 (14) : 1506 - 1511
[8] PERSPECTIVE ON SIGNIFICANCE OF PANDEMIC INFLUENZA
KAVET, J
[J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1977, 67 (11) : 1063 - 1070
[9] KLARMAN H, 1976, INFLUENZA VIRUS VACC
[10] COST-EFFECTIVE ANALYSIS OF INFLUENZA VACCINATION IN THE ELDERLY
MAUCHER, JM
GAMBERT, SR
[J]. AGE, 1990, 13 (04) : 81 - 85